| dc.contributor.author | Freeman, Jane | |
| dc.contributor.author | Baines, Simon D. | |
| dc.contributor.author | Jabes, Daniela | |
| dc.contributor.author | Wilcox, Mark H. | |
| dc.date.accessioned | 2013-08-22T11:45:02Z | |
| dc.date.available | 2013-08-22T11:45:02Z | |
| dc.date.issued | 2005-09 | |
| dc.identifier.citation | Freeman , J , Baines , S D , Jabes , D & Wilcox , M H 2005 , ' Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection ' , Journal of Antimicrobial Chemotherapy , vol. 56 , no. 4 , pp. 717-25 . https://doi.org/10.1093/jac/dki321 | |
| dc.identifier.issn | 0305-7453 | |
| dc.identifier.uri | http://hdl.handle.net/2299/11442 | |
| dc.description.abstract | Treatment of Clostridium difficile infection (CDI) is limited primarily to either metronidazole or vancomycin. We compared vancomycin and a novel glycolipodepsipeptide, ramoplanin, in both hamster and in vitro gut models of clindamycin-induced CDI. | en |
| dc.format.extent | 9 | |
| dc.format.extent | 249108 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Journal of Antimicrobial Chemotherapy | |
| dc.title | Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection | en |
| dc.contributor.institution | School of Life and Medical Sciences | |
| dc.contributor.institution | Microbiology and Biotechnology | |
| dc.contributor.institution | Biosciences Research Group | |
| dc.contributor.institution | Centre for Research in Mechanisms of Disease and Drug Discovery | |
| dc.contributor.institution | Department of Clinical, Pharmaceutical and Biological Science | |
| dc.contributor.institution | Centre for Future Societies Research | |
| dc.description.status | Peer reviewed | |
| rioxxterms.versionofrecord | 10.1093/jac/dki321 | |
| rioxxterms.type | Journal Article/Review | |
| herts.preservation.rarelyaccessed | true | |
